Patients with three-vessel coronary artery disease have been found to have better outcomes with coronary-artery bypass grafting (CABG) than with percutaneous coronary intervention (PCI), but studies ...

The intensity of antiplatelet therapy during percutaneous coronary intervention (PCI) is an important determinant of PCI-related ischemic complications. Cangrelor is a potent intravenous adenosine ...

Percutaneous coronary intervention (PCI) is a procedure that opens blocked arteries and restores blood flow to the heart. Timely access to hospitals offering PCI services can be a matter of life or ...

A recent study found chronic kidney disease (CKD) to be an independent risk factor for incident heart failure with reduced ejection fraction (HFrEF) following percutaneous coronary intervention (PCI).

Facilitated percutaneous coronary intervention (PCI) refers to using fibrinolytic therapy to stabilize the patient while transport is being arranged to a primary PCI facility. This strategy receives a ...

A statewide effort to get hospitals in Michigan to lower their procedural radiation levels for PCI resulted in a steady decrease over a 6-year period, new data show. “We were really pleased to see ...

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout ...

Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...

In findings that run counter to those informing current guidelines, data from the National Cardiogenic Shock Initiative (NCSI) suggest that with early percutaneous mechanical circulatory support, ...

Washington, D.C. – May 1, 2025 – New findings from FAVOR III China Trial, presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific ...